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Chlamydia trachomatis is a leading cause of genital
and ocular infections for which no vaccine exists.
Upon entry into host cells, C. trachomatis resides
within a membrane-bound compartment—the inclu-
sion—and secretes inclusion membrane proteins
(Incs) that are thought to modulate the host-bacte-
rium interface. To expand our understanding of Inc
function(s), we subjected putative C. trachomatis
Incs to affinity purification-mass spectroscopy (AP-
MS). We identified Inc-human interactions for 38/58
Incs with enrichment in host processes consistent
with Chlamydia’s intracellular life cycle. There is
significant overlap between Inc targets and viral
proteins, suggesting common pathogenic mecha-
nisms among obligate intracellular microbes. IncE
binds to sorting nexins (SNXs) 5/6, components of
the retromer, which relocalizes SNX5/6 to the in-
clusion membrane and augments inclusion mem-
brane tubulation. Depletion of retromer components
enhances progeny production, revealing that retro-
mer restrictsChlamydia infection. This study demon-
strates the value of proteomics in unveiling host-
pathogen interactions in genetically challenging
microbes.
INTRODUCTION
Intracellular pathogens that replicate within a membrane-bound
compartment employ secreted virulence factors to subvert the
host and facilitate survival. Decoding these interactions has
been especially difficult for genetically challenging organisms,
such as Chlamydiae. These obligate intracellular pathogens are
important causes of human disease for which no effective vac-Cellcine exists. C. trachomatis is the major cause of noncongenital
blindness worldwide and a leading cause of sexually transmitted
diseases and noncongenital infertility inWestern countries (Man-
dell et al., 2010). C. pneumoniae is an important cause of respi-
ratory infections and is linked to a number of chronic diseases
(Leonard and Borel, 2014). Although treatable with antibiotics,
no drug is cost effective enough for widespread elimination of
disease in developing nations.
All Chlamydiae share a common intracellular life cycle, alter-
nating between an infectious, spore-like elementary body (EB)
and a noninfectious, metabolically active reticulate body (RB)
(reviewed in Bastidas et al., 2013). Upon entry into nonphago-
cytic cells, the EB resides within a membrane-bound compart-
ment—the inclusion—and quickly diverges from the canonical
endolysosomal pathway. The EB differentiates into an RB and
replication commences. After replicating within the ever-
enlarging inclusion over 24–72 hr, the RB redifferentiates to an
EB and is then released, ready to infect neighboring cells.
How Chlamydia establishes its replicative niche is incom-
pletely understood. Chlamydia manipulates the actin cytoskel-
eton and microtubule-based motors; obtains nutrients; interacts
with numerous host cell organelles; and inhibits the innate im-
mune system, autophagy, and programmed cell death (Bastidas
et al., 2013). However, the Chlamydia factors and host cell pro-
teins that mediate these events are largely unknown.
Despite their small genome size, Chlamydia are estimated to
encode a disproportionate number of secreted virulence effec-
tors, 10%–15% of their genome (Betts-Hampikian and Fields,
2010). A large subset of effectors, termed inclusion membrane
proteins (Incs), are translocated by the type III secretion system
and inserted into the inclusion membrane (Moore and Ouellette,
2014). Their defining feature is the presence of one or more
unique bilobed domains, typically composed of two closely
spaced transmembrane regions separated by a short loop
(Bannantine et al., 2000) (Figure 1A). Once inserted into the inclu-
sion membrane, Incs are predicted to extend their termini into
the host cytoplasm (Rockey et al., 2002), ideally positioning
them at the host-pathogen interface. Given the only recent andHost & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc. 109
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Human Interactome
(A) Predicted topology of Inc proteins in the Chla-
mydia inclusion membrane.
(B) Workflow summary.
(C) Overlap of Chlamydia prey with previously
published AP-MS interactomes of HIV (Ja¨ger et al.,
2012), HCV (Ramage et al., 2015), and KSHV (Davis
et al., 2015). p values were determined by the hy-
pergeometric test.
(D) Number of prey shared between Chlamydia
Incs and viral interactomes.
(E) Bar graph depicting the percentage of Inc prey.
For the prey identified for 38 Incs (‘‘All’’), 56%
of prey were affinity purified by core Incs, while
44% of prey were affinity purified by noncore Incs.
Of the 98 prey shared byChlamydia Incs and one or
more virus (‘‘with viral overlap’’), there was a sta-
tistically significant increase in core Incs that
overlap with viral prey (68%) versus noncore Incs
(32%). There was no significant change in the
percentage of prey bound to core versus noncore
Incs for the 237 prey not shared with viruses
(‘‘without viral overlap’’). p < 0.01 determined by
the hypergeometric test. See also Figure S1,
Table S1, and Table S3.limited ability to genetically modify Chlamydia, a detailed under-
standing of the roles of Incs during infection has been chal-
lenging. Indeed, only a few host-binding partners of Incs have
been identified (Moore and Ouellette, 2014). Furthermore, Incs
share little homology to each other or to known proteins,
providing limited insight to their functions (Dehoux et al., 2011;
Lutter et al., 2012).
We used large-scale AP-MS to comprehensively identify pro-
tein-protein interactions (PPIs) between C. trachomatis Incs and
the host proteome to decode mechanisms by which this path-
ogen establishes its privileged intracellular niche. Our analysis
has uncovered a wealth of previously unidentified Chlamydia
Inc-host interactions. We analyzed in detail the interaction be-
tween IncE, an early expressed Inc of unknown function, and
the SNX-BAR proteins, a subset of retromer components. We
found that IncE directly binds the PX domains of SNX5/6, that
IncE is sufficient to disrupt retromer trafficking, and that retromer
restricts C. trachomatis infection. Our study underscores the po-
wer of using comprehensive proteomics to study host-pathogen
interactions, particularly for genetically challenging organisms
such as Chlamydia.
RESULTS
AP-MS Identifies High-Confidence Inc-Human PPIs
We cloned nearly all (58) of the 62 predicted C. trachomatis Incs
(Dehoux et al., 2011; Lutter et al., 2012) from two C. trachomatis
orfeomes (Roan and Starnbach, 2006; Sisko et al., 2006),
including the full-length proteins and/or the predicted cyto-
plasmic domains. Twenty-four of these Incs are evolutionarily
conserved among five or more Chlamydia species (‘‘core’’
Incs) (Dehoux et al., 2011; Griffiths et al., 2006; Lutter et al.,
2012). A total of 78 Inc constructs were fused to Strep tags, tran-110 Cell Host & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Insiently expressed in HEK293T cells, and affinity purified (AP) over
Strep-Tactin beads. Entire eluates were subjected to MS (Fig-
ure 1B). All APs were performed in at least triplicate and
confirmed by immunobloting with an anti-Strep antibody and sil-
ver staining (data not shown). From over 250 AP-MS runs, we
identified 30,924 PPIs (see Table S1 available online), represent-
ing 2,982 unique human proteins.
A set of high-confidence PPIs was established by analyzing
the complete data set using two algorithms: MiST (Ja¨ger et al.,
2012) and CompPASS (Sowa et al., 2009) (Table S1). Using strin-
gent criteria (MiST score R 0.7 or the top 1% of CompPASS
scores), we identified 354 high-confidence Inc-human PPIs, rep-
resenting 335 unique host binding partners for 38/58 Incs (Table
S1; Figure S1). Importantly, IncD and CT228 coeluted their
known human targets, CERT (Derre´ et al., 2011) andMYPT1 (Lut-
ter et al., 2013), respectively, as the highest-confidence PPI
(Table S1). These findings establish the validity of our scoring
system and demonstrate that our pipeline correctly identifies
biologically confirmed PPIs for transmembrane proteins such
as the Incs.
Constructing a Comprehensive Inc-Human PPI Network
We assembled an Inc-human PPI network using two databases
of known human-human protein interactions (CORUM [Ruepp
et al., 2010] and STRING [Franceschini et al., 2013]) to identify
multiprotein complexes and potential connections between
Incs (Figure 2). Within this subset, we found individual Incs that
associate with several members of multiprotein complexes,
including retromer, COP9 signalosome, condensin II, GINS,
and dynactin. We also observed numerous examples of two or
more individual Incs that interact with the same host complex.
For example, five Incs (CT005, CT556, CT195, CT058, and
CT819) interacted with members of the TIM-TOM complex,c.
Figure 2. Network Representation of the Inc-Human Interactome
The high-confidence Inc-host network contains 38 Inc proteins (core Incs, dark gray; non-core Incs, light blue), and 335 unique human prey (light gray). Inc-human
interactions (blue lines) were identified by AP-MS. Interactions between human proteins (dark gray lines) were curated fromCORUMand STRING databases. Inc-
human prey in common with HIV, KSHV, or HCV prey (Davis et al., 2015; Ja¨ger et al., 2012; Ramage et al., 2015) are outlined in red. A subset of identified host
complexes or proteins with similar functions are labeled. See also Table S2.hostmachinery responsible for mitochondrial protein import (Ba-
uer et al., 2000). Three Incs (CT135, CT565, and CT357) each
bind to different subunits of vacuolar ATPases, multiprotein en-
zymes that control acidification of intracellular organelles
(Marshansky and Futai, 2008). We also identified several Incs
that target proteins involved in ubiquitination, consistent with aCellrecent report that C. trachomatis remodels the host proteome
(Olive et al., 2014). Finally, we found a subset of host proteins
(RTN4, VKORC1L1, CPVL, LRRC59, WDR6 VPRBP, and
RNH1) that were each targeted by two individual Incs, suggest-
ing that modulating these targets may be critical for Chlamydia’s
intracellular survival.Host & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc. 111
Figure 3. Predicted Functions for Specific Incs
Schematic diagram of the Chlamydia developmental cycle, indicating predicted functions of putative Incs derived from GO, KEGG, and PFAM enrichment terms
from the entire PPI data set (see Table S2). Core Incs, black; Noncore Incs, blue. Note that some predicted Incs have not been observed on the inclusion
membrane at 24 hpi (Li et al., 2008, Dehoux et al., 2011). See also Table S1 and Figures S2 and S3.The Inc-Human Interactome Predicts Inc Functions
during Chlamydia Development
Analysis of the entire data set with gene ontology (GO) and pro-
tein database (KEGG and PFAM) terms revealed that Inc-host
protein interactions were enriched for many compartments and
pathways consistent withChlamydia’s intracellular life cycle (Fig-
ures 3, S2, and S3; Table S2). For example, we found increased
representation for host proteins that localize to the ER, Golgi,
mitochondria, endosomes, lysosomes, and actin cytoskeleton,
all of which associate with the C. trachomatis inclusion (Bastidas
et al., 2013). We also identified host targets enriched for biolog-
ical processes and molecular functions known to be modulated
during infection, such as endocytosis, ubiquitination, apoptosis,
cell cycle/division, and DNA damage/repair (Bastidas et al.,
2013).
Our analysis uncovered cellular processes that may be modu-
lated by Chlamydia, such as chromosome condensation (Con-
densin II complex), splicing (SMN complex), retromer trafficking
(SNXs), and the cytosolic surveillance response (DNA/RNA sen-
sors) (Figures 2, S2, and S3; Table S2). Our PPI data set allows us
to now link specific Incs to host cell processes important for
infection (Figure 3).
Chlamydial and Viral Effectors Share Host Protein
Targets
To determine whether diverse intracellular pathogens target host
proteins in common with each other, we compared our Inc-hu-
man interactome to three recently assembled virus-human inter-
actomes: HIV (Ja¨ger et al., 2012), KSHV (Davis et al., 2015), and
HCV (Ramage et al., 2015). These viral interactomes were
derived using the same pipeline that we employed, providing112 Cell Host & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inan opportunity for cross-pathogen analyses. We found a signif-
icant overlap in high-confidence prey between Chlamydia and
each of the three viruses (Figure 1C; Table S3). We identified
98 high-confidence C. trachomatis prey shared with one or
more viruses, 10 shared with 2 or more viruses, and 2 shared
with all 3 viruses (Figure 1D). Host complexes or pathways tar-
geted byChlamydia and one or more viruses included lysosomal
ATPases, DNA repair, the TIM-TOM complex, the dynactin com-
plex, the ubiquitin machinery, and Golgi trafficking (Figure 2).
Strikingly, we found core Incs were more likely to overlap with
viral targets compared to non-core Incs (p < 0.001; Figure 1E;
Table S3).
IncE Interacts with Retromer-Associated Sorting Nexins
Our interactome revealed that IncE was enriched for retromer-
associated proteins, including SNX1, SNX2, SNX5, and SNX6
(SNX1/2/5/6) (Figures S2 and 2; Table S2). IncE, located in an
operon together with IncD, IncF, and IncG, is expressed within
the first 2 hr of C. trachomatis infection (Scidmore-Carlson
et al., 1999), but its function(s) and host binding partners
were unknown. The retromer complex is composed of the
vacuolar protein sorting (VPS) trimer and a heterodimer of
SNX-BAR proteins, SNX1/2-SNX5/6 (Cullen and Carlton,
2012; Teasdale and Collins, 2012). SNX-BAR proteins are
comprised of a phosphoinositide-binding Phox homology (PX)
domain, which functions in endosomal membrane trafficking,
membrane remodeling, and organelle motility (Cullen and Kors-
wagen, 2012; Seaman, 2012), and a Bin-amphiphysin-Rvs
(BAR) domain, which both senses and induces membrane cur-
vature (Teasdale and Collins, 2012). By inducing tubulation and
then recruiting additional factors that lead to scission andc.
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Figure 4. IncE Interacts with Retromer SNX-BARs In Vivo and In Vitro
(A) Affinity purifications of HEK293T cells transiently expressing Strep-tagged Incs and immunblotted with the indicated antibodies.
(B and C) IncE interacts with endogenous SNX6 (B) and transiently expressed SNX5-FLAG (C) in vivo. Immunoblot analysis of immunoprecipitations with anti-
SNX6, anti-FLAG, or anti-goat IgG in HeLa cells uninfected () or infected (+) with C. trachomatis (C.t.) for 24 hr. Input represents 1% of lysates used for
immunoprecipitation. Immunoblots are representative ofR3 independent experiments. Untransfected, UT.
(D) Schematic of IncE deletion constructs. The predicted transmembrane (TM) domains are shaded in black; the predicted N- and C-terminal cytosolic domains
are shaded in gray. The numbers refer to amino acids. Constructs that coaffinity purify with SNX-BARs are indicated.
(E) Affinity purifications of Strep-tagged IncE deletion constructs transiently expressed in HEK293T cells.
(F) IncE101–132 binds the PX domains of SNX5 and SNX6 in vitro. Purified 6xHis-MBP-Inc-Strep protein was immobilized to Strep-Tactin beads and incubated with
the indicated purified 8xHis-SNXPX, subjected to SDS-PAGE, and visualized by Coomassie blue stain. Arrow, IncE or IncD. Arrowhead, SNXPX. Asterisk, Strep-
Tactin. Molecular weight markers are indicated. See also Figure S4.formation of vesicles, the retromer SNX-BARS facilitate sorting
of protein receptors between endosomes and the trans-Golgi
network (Cullen and Carlton, 2012; Seaman, 2012). All four
retromer SNX-BARs (SNX1/2/5/6) were identified as very-
high-confidence targets of IncE (MiST > 0.96; top 0.002% of
CompPASS) (Table S1).
We confirmed that IncE interacts specifically with retromer
SNX-BARs in vivo. Endogenous retromer SNX-BARs coaffinity
purified with transiently expressed IncE, but not IncD, IncF, or
IncG (Figures 4A and S4A). In C. trachomatis-infected cells,
IncE coimmunoprecipitated with endogenous SNX6 (Figure 4B)
or with transfected FLAG-SNX5, but not transfected FLAG-
SNX14 (Figure 4C), revealing that IncE specifically binds
SNX5/6 in vivo.
We tested informative deletion mutants of IncE-Strep (Fig-
ure 4D) by transient expression in HEK293T cells and found
that only mutants containing the IncE C-terminal cytoplasmic
domain (IncE101–132) coaffinity purified with retromer SNX-
BARs (Figures 4E and S4B). AP-MS of IncE101–132 also identi-Cellfied retromer SNX-BARs as the highest confidence PPIs
(Table S1). Finally, IncE101–132-EGFP colocalized with endoge-
nous SNX1, SNX2, SNX6, and transiently expressed FLAG-
SNX5 in endosomes, as visualized by confocal microscopy
(Figure S4C). Together, these results show that IncE101–132 is
both necessary and sufficient to interact specifically with retro-
mer SNX-BARs.
IncE101–132 Binds Directly to the PX Domains of SNX5
and SNX6
To determine whether IncE101–132 binds directly to one or more
retromer SNX-BARs, we performed in vitro pull-downs with
6xHis-MBP-IncE-Strep and 8xHis- or 6xHis-MBP-SNXs individ-
ually purified from E. coli. IncE101–132 directly bound to the PX do-
mains of SNX5 and SNX6, but failed to bind the corresponding
PX domains of SNX1 or SNX2. The C-terminal cytoplasmic
domain of IncD, IncD95–141, did not bind the PX domains of retro-
mer SNX-BARs (Figure 4F). Neither IncE101–132 nor IncD95–141
bound the BAR domains of retromer SNX-BARs in vitroHost & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc. 113
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Figure 5. IncE Colocalizes with Retromer
SNX-BARs on the Inclusion
(A–C) HeLa cells were infected with C. trachomatis
(C.t.) for 24 hr and analyzed by confocal micro-
scopy for the localization of (A) endogenous SNX1/
2/6 or transfected SNX5-FLAG and IncE, (B)
SNX27-EGFP (pseudocolored red) and IncE, or (C)
endogenous SNX1 and VPS35. Panels are (A) sin-
gle z slices or (B and C) maximum intensity pro-
jections of 0.3 mm z slices. I, inclusion. N, nucleus.
UI, uninfected. Arrowheads point to tubules. Scale
bar, 10 mm. See also Figure S5.(Figure S4D). Thus, IncE101–132 is sufficient to bind SNX5/6 PX
domains in the absence of other human proteins. PSIPRED pro-
tein sequence analysis revealed that IncE101–132 contains a puta-
tive b-hairpin structure (Figure S4E). In vitro pulldowns of
IncE101–132 truncations (Figure S4E) demonstrated that the
b-hairpin region was required for SNX5 binding (Figure S4F),114 Cell Host & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc.suggesting that this secondary structure
may play a role in the direct binding of
IncE to SNX5/6.
RetromerSNX-BARsColocalizewith
IncE on the Inclusion Membrane
Retromer SNX-BARs primarily colocalize
with PtdIns(3)-rich endosomal membranes
(Cullen and Carlton, 2012; Seaman, 2012).
Confocal microscopy of C. trachomatis-in-
fected cells stained with antibodies to
SNXs and to IncE revealed that at 6 and
24 hr postinfection (hpi), endogenous
SNX1, SNX2, SNX6, and transfected
FLAG-SNX5 colocalized with IncE on the
inclusion membrane (Figures 5A, S5B,
and S5C; data not shown). We also
observed IncE on tubules emanating from
inclusions that were positive for SNX1,
SNX2, FLAG-SNX5, SNX6, and IncA
(Figures 5A and S5A–S5C). In contrast,
SNX27, a retromer-associated SNX
involved in endosome-to-plasma mem-
brane cargo recycling (Lauffer et al.,
2010), was not recruited to the inclusion,
but instead remained localized in punctate
structures (Figures5B). Thus,Chlamydia in-
clusions and tubules specifically associate
with retromer SNX-BARs.
Retromer functions in trafficking cargo-
containing vesicles along microtubules to
the trans-Golgi through the interaction of
SNX6 with dynactin subunit 1 (Hong
et al., 2009). To determine whether Chla-
mydia inclusion tubulation requires
microtubule polymerization, infected cells
were exposed to nocodazole, and tu-
bules were examined by confocal micro-
scopy. Microtubules were required forthe formation of SNX and IncE-positive tubules at 6 hpi (Fig-
ure S5B) and 24 hpi (Figure S5C). However, microtubule poly-
merization was not required for SNX recruitment to inclusions
(Figures S5B and S5C), consistent with our results demon-
strating that IncE directly binds to and likely recruits SNX5/6
to the inclusion.
Chlamydia Inclusions Do Not Stably Associate with the
VPS Subcomplex
In addition to SNX heterodimers, retromer also contains the
tripartite cargo recruitment complex composed of VPS26A,
VPS29, and VPS35 (Seaman, 2012). While retromer SNX-BARs
co-affinity purified with IncE, the VPS subunits and other retro-
mer-associated SNXs were notably absent (Table S1; Figure 4E).
Confocal microscopy of C. trachomatis-infected cells demon-
strated that, in contrast to the robust recruitment of SNX-BARs
to the inclusion membrane, VPS35 (Figure 5C) and GFP-VPS29
(data not shown) remained in punctate structures. Chlamydia
infection significantly diminished SNX1 localization to VPS35-
positive compartments (Figure S5D, p < 0.0001), while total
protein levels were unchanged (Figure S5E), suggesting that
Chlamydia relocalizes SNX-BARs from endosomes to the inclu-
sion membrane.
SNX1 is recruited to early Salmonella-containing vacuoles
(SCVs) (Bujny et al., 2008), so we assessed whether other retro-
mer components are recruited to SCVs. We confirmed SNX1
recruitment (Figure S5F) and also found that SNX2 and VPS35
clearly decorated SCVs and associated tubules (Figures S5G
and S5H). Thus, in contrast to endosomal membrane tubules
or SCVs,Chlamydia inclusions and tubules do notmaintain a sta-
ble association with the VPS complex.
IncE Is Sufficient to Recruit Retromer SNX-BARs
and Induce Inclusion Tubulation
BAR domain-containing proteins form a helical coat, which
impose membrane curvature and remodel membranes into
tubular profiles (Frost et al., 2008). Based on our observation
that retromer SNX-BARs colocalized with IncE on Chlamydia in-
clusion membrane tubules, we predicted that overexpression of
IncE would be sufficient to enhance inclusion tubulation. There-
fore, we transformed C. trachomatis serovar L2, a strain with
lower baseline levels of tubulation compared to serovar D,
with plasmids engineered to express C-terminally FLAG-tagged
IncE (pTet-IncE-FLAG) or IncG (pTet-IncG-FLAG) under a tetra-
cycline (Tc)-inducible promoter. As expected, upon induction
with Tc, IncE-FLAG and IncG-FLAG were readily detected on
the inclusion membrane and tubules (Figure 6A). Importantly, in-
duction of IncE-FLAG was sufficient to enhance recruitment of
SNX6 to the inclusion (Figures 6B and 6C) and to enhance for-
mation of IncA-positive (Figure S6A) and SNX6-positive (Fig-
ure 6C) tubules compared to IncG-FLAG or uninduced controls.
We also observed increased SNX6 recruitment and SNX6-pos-
itive tubules in C. trachomatis transformed with a vector
expressing untagged IncE (pIncE) under control of its native pro-
moter compared to C. trachomatis transformed with empty
vector (Figures 6D and 6E). IncE expression in C. trachomatis-
transformed strains was verified by immunoblot analysis (Fig-
ures S6B and S6C). We conclude that IncE expression is suffi-
cient to enhance SNX6 inclusion recruitment and inclusion
tubulation.
We used siRNA depletion to determine if retromer function is
required for inclusion tubulation. Due to functional redundancy
of retromer SNX-BARs (Seaman, 2012), we simultaneously
depleted cells of SNX1 and SNX2, SNX5, and SNX6; all four
SNXs; or VPS35 (Figure S6D). Depletion of any retromer compo-
nent decreased both the length and number of inclusion tubulesCell(Figures 6F and S6E), consistent with our model that recruitment
of SNX-BARS enhances inclusion tubulation.
IncE Disrupts Retromer-Dependent Trafficking of the
Cation-Independent Mannose-6-Phosphate Receptor
Since IncE bound SNX5/6 in vitro (Figure 4F), andC. trachomatis
infection caused relocalization of SNX5/6 from endosomes to
the inclusion membrane (Figures 5A), we tested whether IncE
could interfere with retromer-dependent trafficking. For these
experiments, we transfected cells with IncE101–132-EGFP, or,
as a control, IncD95–141-EGFP, and analyzed localization of the
retromer trafficked cation-independent mannose-6-phosphate
receptor (CI-MPR), a well-established assay for retromer func-
tion (Arighi et al., 2004; Wassmer et al., 2007). Compared to un-
transfected cells or transfection with IncD95–141, transfection
with IncE101–132-EGFP changed the distribution of CI-MPR
from juxtanuclear TGN46-positive compartments to a more
disperse collection of large vesicles (Figure 7A). Concomitantly,
there was decreased colocalization between CI-MPR and
TGN46 (Figure 7B). Instead, CI-MPR largely overlapped with
VPS35 and IncE101–132-EGFP (Figure 7C), indicating that
IncE101–132-EGFP expression is sufficient to maintain CI-MPR
in retromer-containing compartments, thereby disrupting effi-
cient CI-MPR trafficking to the trans-Golgi.
Retromer SNX-BARs Restrict C. trachomatis Infection
As IncE101–132 expression altered retromer trafficking, we tested
the hypothesis that retromer may be detrimental to
C. trachomatis infection. Depletion of SNX5/6 or all four retro-
mer SNX-BARs significantly enhanced production of infectious
progeny (Figure 7D), suggesting that retromer SNX-BARs
restrict C. trachomatis infection. While we observed a trend to-
ward enhanced progeny with VPS35 depletion, it did not reach
statistical significance (p = 0.0574). Enhanced progeny could
not be explained by an increase in primary infection; in fact,
we noted a significant decrease in primary inclusion formation
upon SNX1/2 depletion (Figure 7E). Thus, SNX1/2 may partici-
pate in early stages of infection, which could explain the more
modest effect of SNX1/2 depletion on infectious progeny pro-
duction (Figure 7D). Altogether, our results support a model
(Figure S7) whereby IncE directly binds SNX5/6, which redirects
the retromer SNX-BAR subcomplex to the inclusion membrane,
with two functional consequences. First, recruitment of SNX-
BARS induces inclusion membrane tubulation, likely through
the well-studied ability of BAR domain proteins to induce
membrane curvature. Second, by sequestering SNX-BARs at
the inclusion and potentially disrupting retromer function,
C. trachomatis relieves the restriction that retromer imposes
on infection.
DISCUSSION
Assigning functions to individual Chlamydia effectors has been
difficult in the absence of robust genetic approaches. In this
study, we applied an unbiased systematic AP-MS approach to
comprehensively identify putative host targets of Incs, effectors
that are ideally poised to orchestrate host-pathogen interac-
tions. Our work is especially valuable because very few Inc tar-
gets had been identified.Host & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc. 115
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Figure 6. IncE Is Sufficient to Enhance SNX-BAR Recruitment and Inclusion Tubulation
(A–C) HeLa cells were infected with C. trachomatis serovar L2 transformed with pTet-IncE-FLAG or pTet-IncG-FLAG. As indicated, Tc was added at 1 hpi. At
20 hpi, cells were analyzed by confocal microscopy for (A) FLAG or (B and C) SNX6. (A and B) Maximal intensity projections of 0.2 mm z slices. (C) showsmaximal
intensity projections and single XY slices from the boxed region in (B). Scale bar, 10 mm.
(D and E) HeLa cells were infected withC. trachomatis serovar L2 transformed with empty vector or pIncE. At 15 hpi, cells were fixed and stained with anti-SNX6,
IncE, and DAPI. (E) shows enlargement of boxed region of (D). All images are maximum intensity projections. Scale bar, 10 mm.
(F) Quantitation of inclusion tubules per cell (dark gray bars) and length of the longest tubule per cell (light gray bars) (mm) in C. trachomatis-infected HeLa cells
depleted of the indicated retromer components by siRNA. Data are mean ± SEM from three independent experiments. *p < 0.001 compared to corresponding
control, unpaired (two-tailed) t test. See also Figure S6.
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As with any AP-MS approach, false positives and false nega-
tives are unavoidable. We employed two stringent scoring algo-
rithms, MiST and CompPASS, to minimize false positives. Tech-
nical limitations of AP-MS may lead to false negatives
(Verschueren et al., 2015), which could explain our failure to iden-
tify the following interactions: 14-3-3b and IncG (Scidmore and
Hackstadt, 2001), Rab4 and CT229, (Rzomp et al., 2006), or
VAMPs and IncA (Delevoye et al., 2008). Our inability to identify
high-confidence PPIs for 1/3 of Incs could be explained if (1)
the Inc serves a structural role in the inclusion membrane (Mital
et al., 2013), (2) the host target is a lipid (Mital et al., 2013), or
(3) multiple Incs function together to form a binding interface
(Gauliard et al., 2015; Mital et al., 2010). Importantly, some puta-
tive Incs have not been observed on the inclusion membrane at
24 hpi (Dehoux et al., 2011; Li et al., 2008; summarized in Table
S1); however, their localization may be stage, cell type, or sero-
var specific. Of the 20 Incs whose membrane localization has
been experimentally verified (Dehoux et al., 2011; Li et al.,
2008), we identified high-confidence host targets for 15 Incs
(75%) and validated two published Inc-host interactions (Derre´
et al., 2011; Lutter et al., 2013). Overall, this Inc-host interactome
allows us to link host processes to specific Incs and identifies a
plethora of Inc-human interactions of significant biological inter-
est that merit further investigation.
Our standardized AP-MS pipeline provides an unprecedented
opportunity to learn whether diverse intracellular pathogens use
common strategies to survive. Not only did we observe a signif-
icant overlap between the interactomes of C. trachomatis and
three human viruses, but we found that the more evolutionarily
conserved core Incs are more likely to share host targets with
viral effectors. Comparison of the overlap among all four patho-
gens revealed two common targets, MSH2 and UBE2O, sug-
gesting that these host proteins may be critical for intracellular
pathogen survival. Modulating UBE2O, one of 35 human E2
ubiquitin ligases, is particularly intriguing, as it may be an efficient
way for intracellular pathogens to regulate the stability of a
distinct subset of host proteins.
Our Inc-human PPI network reveals an interaction between
IncE and retromer SNX-BARs, which are involved in tubular-
based endosomal trafficking (Seaman, 2012). SNX-BAR recruit-
ment to membranes typically involves binding of SNX-PX
domains to endosome-specific PtdIns(3)P (Cullen and Carlton,
2012; Seaman, 2012). Our work suggests that SNX5/6 bind
directly to IncE independently of phosphoinositides and that
the predicted IncE C-terminal b-hairpin is required. Our findings
expand the emerging concept that PX domains function not only
as lipid recognition modules but also as PPI domains (Teasdale
and Collins, 2012). While the molecular details of the IncE-SNX5/
6 interaction await further investigation, we note that SNX5/6
contain a unique double PXXPmotif with an adjacent30 amino
acid insertion that forms a long helical hairpin (Koharudin et al.,
2009), which distinguishes SNX5/6 from SNX1/2. This feature
may contribute to the recognition of SNX5/6 by IncE.
Our data predict that by sequestering SNX-BARs, IncE could
disrupt retromer trafficking. To examine retromer trafficking in
Chlamydia-infected cells, we used an assay that did not directly
involve retromer cargo as a readout, since full-length IncE may
bind cargo directly (Table S1) and the CI-MPR localizes to the in-
clusion membrane (van Ooij et al., 1997; our unpublished data).CellWe examined processing and release of cathepsin D, a secreted
lysosomal protease that is missorted when retromer trafficking is
disrupted (Rojas et al., 2008). We were unable to demonstrate
robust intracellular accumulation of the incompletely processed
forms (our unpublished data), as reported upon depletion of
VPS26 or Rab7 (Rojas et al., 2008), which could be explained if
Chlamydia also alters secretory pathways. We do show that
ectopic expression of IncE101–132, which does not appear to
bind cargo (Table S1), alters CI-MPR localization in a manner
similar to what is observed upon SNX5/6 depletion (Wassmer
et al., 2007).
We observed a profound increase in infectious progeny pro-
duction upon SNX5/6 depletion, which we postulate recapitu-
lates IncE-mediated recruitment of the SNX-BAR complex
away from retromer-containing compartments to the inclusion
membrane. As primary inclusion formation was not enhanced,
we predict that SNX5/6 restricts Chlamydia infection at later
steps in the life cycle, such as replication, RB to EB conversion,
EB escape, or EB infectivity. While the mechanism by which
SNX5/6 restricts bacterial development is not clear, it could be
through retromer-dependent or retromer-independent path-
ways. For example, retromer trafficking may contribute to the
recognition or clearance of Chlamydia. Alternatively, since retro-
mer is required to maintain the integrity of the trans-Golgi
(Wassmer et al., 2007), IncE-mediated sequestration of retromer
SNX-BARSmay promote Golgi fragmentation, a process that fa-
cilitates lipid acquisition by C. trachomatis and enhances prog-
eny production (Heuer et al., 2009). Finally, SNX5/6 may have
other roles outside of retromer trafficking (Sun et al., 2013) that
contribute to Chlamydia restriction.
Our results provide mechanistic insights into the formation of
Chlamydia inclusion tubulation. We demonstrate that IncE and
SNX-BARs colocalize on the inclusion membrane and tubules,
that ectopic expression of IncE is sufficient to induce inclusion
tubulation, and that depletion of retromer components limits
inclusion tubulation. The direct recruitment of BAR-domain-con-
taining proteins to the inclusion membrane provides a mecha-
nistic link to tubulation, as these proteins are necessary and suf-
ficient for membrane deformation and endosomal tubule
formation (Frost et al., 2009). While the role of the tubules is
not entirely understood, they are proposed to play a role in sec-
ondary inclusion formation (Suchland et al., 2005). We demon-
strate that inclusion tubulation and infectious progeny produc-
tion can be uncoupled: SNX5/6 depletion, which abrogates
tubulation, leads to increased infectious progeny.
Our work highlights the strategies employed by diverse intra-
cellular pathogens to repurpose retromer. Silencing of retromer
components abrogates HIV (Groppelli et al., 2014), HPV (Lipov-
sky et al., 2013), Coxiella (McDonough et al., 2013), and Salmo-
nella (Bujny et al., 2008) infections. Our finding that VPS35 is
readily recruited to SCVs reveals that Salmonella recruits the
VPS complex in addition to retromer SNX-BARs. In contrast,
Chlamydia IncE selectively recruits retromer SNX-BARs without
stably recruiting VPS components or SNX27. Interestingly,
through an entirely different mechanism, Legionella also disas-
sociates retromer subcomplexes by sequestering VPS compo-
nents and blocking SNX-PtdIns(3)P binding (Finsel et al., 2013).
In summary, we have applied AP-MS to create a global
network of C. trachomatis Inc-host PPIs, providing aHost & Microbe 18, 109–121, July 8, 2015 ª2015 Elsevier Inc. 117
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Figure 7. IncE101–132-EGFP Disrupts Retromer Trafficking, and Retromer Depletion Restricts C. trachomatis Infection
(A) Localization of endogenous CI-MPR is perturbed in HeLa cells transiently transfected with IncE101–132-EGFP, but not IncD95–141-EGFP, compared to un-
transfected (UT). Cells were fixed and stained with antibodies to TGN46, CI-MPR, and costainedwith DAPI. Shown are single z slices from confocal images. Scale
bar, 10 mm.
(B) Quantitation of TGN46 colocalizationwith CI-MPR in cells expressing IncE101–132-EGFP or IncD95–141-EGFP.Mean Pearson’s correlation coefficients from two
independent experiments (n = 20 cells per experiment). *p < 0.05 compared to UT or IncD, using one-way ANOVA, post hoc Tukey’s test.
(legend continued on next page)
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comprehensive bacterial effector-host interactome. Our analysis
has uncovered a wealth of previously unidentified Chlamydia
Inc-host interactions. By linking individual Incs to specific host
processes, our work, in conjunction with the development of ge-
netic tools to generate targeted null mutants inChlamydia (John-
son and Fisher, 2013), sets the stage to test the functional role of
Incs. This methodology has broad applicability to the study of
pathogenesis and is equally effective for identifying the targets
of bothmembrane-bound and soluble effectors.We have uncov-
ered overlapping and potentially druggable pathways targeted
by viral and bacterial pathogens. Finally, investigation of the
IncE-SNX5/6 interaction may provide insight into retromer
biology.
EXPERIMENTAL PROCEDURES
Cell Culture, Transformations, and Bacterial Propagation
HeLa and HEK293T cells were maintained under standard conditions.
C. trachomatis serovar D and L2 were propagated as previously described (El-
well et al., 2011). Chlamydia transformations were performed as previously
described (Agaisse and Derre´, 2013; Wang et al., 2013).
Affinity Purification and Mass Spectrometry
Affinity purifications were performed as previously described (Ja¨ger et al.,
2012). Eluates were processed, trypsin digested, and concentrated for LC-
MS/MS. Digested peptide mixtures were analyzed on a Thermo Scientific
Velos Pro ion trap MS system equipped with a Proxeon Easy nLC II high-pres-
sure liquid chromatography and autosampler system.
Scoring and Analyzing the Inc-Host Interactome
AP-MS samples were scored with CompPASS (Sowa et al., 2009) and MIST
algorithms, using MiST weights optimized for the KSHV-host interactome (Da-
vis et al., 2015). The scored data set included a subset of Chlamydia secreted
effectors that will be published independently. All bait-prey pairs with a MiST
score R 0.70 or the top 1% of the CompPASS WD scores were combined
with human protein interactions from CORUM and STRING databases that
connect prey. The resulting network diagram was plotted using Cytoscape,
v.3.1.2 (Smoot et al., 2011). All scored preys were queried against GO,
KEGG, and PFAM ontologies for functional and domain annotations. Terms
were manually curated, and baits were analyzed for significantly enriched
terms with a resampling procedure using MiST scores. Viral overlap was per-
formed as previously described (Davis et al., 2015), and statistical analysis was
performed using the hypergeometric test.
Infections and RNAi
Cells were infected with Chlamydia for 1 hr and then incubated for 15–24 hr
(primary infection, tubulation or immunoprecipitation) or 72 hr (progeny pro-
duction). For some experiments, nocodazole or Tcwas added 1 hpi. HeLa cells
were transfected with siRNAs (Dharmacon) according to manufacturer’s pro-
tocols and infected with Chlamydia at 48 hr. Protein depletion was assayed by
immunoblot.
Transfections and Immunoprecipitations
Lysates from HeLa cells collected 24 hpi were immunoprecipitated with con-
trol IgG or anti-SNX6 antibody using Protein G Dynabeads (Invitrogen). Alter-
natively, HeLa cells were transfected (Effectene, QIAGEN) with the indicated
FLAG-SNX construct, infected 24 hr later with C. trachomatis, collected at(C) CI-MPR remains localized to VPS35-positive compartments in cells expressing
with antibodies to VPS35 and CI-MPR, and costained with DAPI. Shown are sing
yellow arrows, CI-MPR-positive compartment. (Left panel) (Merge) Scale bar, 5 m
(D and E) Quantitation of infectious progeny (D) or primary infection (inclusion
depletion of the indicated retromer components. Data are mean ± SEM fromR 3
t test.
Cell24 hpi, immunoprecipitated with anti-FLAG beads (Sigma), and eluted with
FLAG peptide.
Microscopy
HeLa cells were grown on glass coverslips, infected with Chlamydia, fixed,
stained with the indicated primary and fluorophore-conjugated secondary
antibodies, and mounted with Vectashield containing DAPI (Vector Labora-
tories). Images were acquired using Yokogawa CSU-X1 spinning-disk
confocal mounted on a Nikon Eclipse Ti inverted microscope equipped
with an Andora Clara digital camera. Images were acquired and processed
using NIS-Elements software 4.10 (Nikon). Quantitations of tubule number/
length and colocalization were performed using Nikon Elements. Inclusions
were quantified using the Spot function in Imaris. Statistics were performed
using Instat software; p values less than 0.05 were considered statistically
significant.
In Vitro Pull-Downs
Purified 6xHis-MBP-Inc-Strep constructs were immobilized to Strep-Tactin
Sepharose beads according to manufacturer’s instructions (IBA) and incu-
bated with purified 8xHis-SNXPX or 6xHis-MBP-SNXBAR domains (1:2 molar
ratio), the beads were washed extensively, and the complexes were boiled
and analyzed by Coomassie blue staining.
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